JESSICA MARGANSKI: Open Payments
NPI 1619661063 · PALOS PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 38 payments from 11 companies in 2025. Trend: 2023 $249 · 2024 $211 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $167 |
| Actelion Pharmaceuticals US, Inc. | 4 | $101 |
| Amgen Inc. | 4 | $71 |
| Merck Sharp & Dohme LLC | 4 | $68 |
| SCPHARMACEUTICALS INC. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Boston Scientific Corporation | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: ELIQUIS, VYNDAQEL, REPATHA, OPSUMIT, VERQUVO, WINREVAIR, FUROSCIX, LEQVIO.
Industry payments across IL — which companies pay providers there.
